The feasibility of ureteral tissue engineering using autologous veins: an orthotopic animal model with long term results

In an earlier study we demonstrated the feasibility to create tissue engineered venous scaffolds in vitro and in vivo. In this study we investigated the use of tissue engineered constructs for ureteral replacement in a long term orthotopic minipig model. In many different projects well functional ureretal tissue was established using tissue engineering in animals with short-time follow up (12 weeks). Therefore urothelial cells were harvested from the bladder, cultured, expanded in vitro, labelled with fluorescence and seeded onto the autologous veins, which were harvested from animals during a second surgery. Three days after cell seeding the right ureter was replaced with the cell-seeded matrices in six animals, while further 6 animals received an unseeded vein for ureteral replacement. The animals were sacrificed 12, 24, and 48 weeks after implantation. Gross examination, intravenous pyelogram (IVP), H&E staining, Trichrome Masson’s Staining, and immunohistochemistry with pancytokeratin AE1/AE3, smooth muscle alpha actin, and von Willebrand factor were performed in retrieved specimens. The IVP and gross examination demonstrated that no animals with tissue engineered ureters and all animals of the control group presented with hydronephrosis after 12 weeks. In the 24-week group, one tissue engineered and one unseeded vein revealed hydronephrosis. After 48 weeks all tissue engineered animals and none of the control group showed hydronephrosis on the treated side. Histochemistry and immunohistochemistry revealed a multilayer of urothelial cells attached to the seeded venous grafts. Venous grafts may be a potential source for ureteral reconstruction. The results of so far published ureteral tissue engineering projects reveal data up to 12 weeks after implantation. Even if the animal numbers of this study are small, there is an increasing rate of hydronephrosis revealing failure of ureteral tissue engineering with autologous matrices in time points longer than 3 months after implantation. Further investigations have to prove adequate clinical outcome and appropriate functional long-term results.

Authors
Engel Oliver1 , De Petriconi Robert2 , Volkmer B.G. 3 , Gust K.M.4 , Mani Jens4 , Haferkamp Axel4 , Hautmann R.E.2 , Bartsch Georg4
Publisher
BioMed Central
Number of issue
1
Language
English
Pages
1-9
Status
Published
Volume
13
Year
2014
Organizations
  • 1 University Medical Center Hamburg-Eppendorf
  • 2 University Medical Center Ulm
  • 3 Department of Urology
  • 4 Johann Wolfgang Goethe University
Keywords
reconstruction; tissue engineering; ureter; Urothelial cells; vein
Date of creation
09.07.2024
Date of change
09.07.2024
Short link
https://repository.rudn.ru/en/records/article/record/134628/
Share

Other records